NASDAQ · ALLR

Allarity Therapeutics, Inc.

Closing price · Nov 13, 2026 $0.9538

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 13, 2026
Revenue growth
—Sales for the quarter: $5K
Cash from operationsBetter
−$2.88M
Quarter ended Dec 31, 2024: −$3.21M cash from operationsQuarter ended Mar 31, 2025: −$2.69M cash from operationsQuarter ended Jun 30, 2025: −$5.48M cash from operationsQuarter ended Sep 30, 2025: −$3.41M cash from operationsQuarter ended Dec 31, 2025: −$3.24M cash from operationsQuarter ended Mar 31, 2026: −$4.49M cash from operationsQuarter ended Jun 30, 2026: −$2.56M cash from operationsQuarter ended Sep 30, 2026: −$2.88M cash from operations
Dec '24Sep '26
vs. −$3.41M a year ago
Share countSteady
+1.2%
Quarter ended Dec 31, 2024: 17.01M sharesQuarter ended Mar 31, 2025: 15.08M sharesQuarter ended Jun 30, 2025: 14.62M sharesQuarter ended Sep 30, 2025: 15.81M sharesQuarter ended Dec 31, 2025: 15.82M sharesQuarter ended Mar 31, 2026: 15.91M sharesQuarter ended Jun 30, 2026: 15.91M sharesQuarter ended Sep 30, 2026: 16M shares
Dec '24Sep '26
16M shares vs. 15.81M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

20 funds report owning ALLR, up from 14

Holdings as of Jun 30, 2026
New8
Added3
Held6
Trimmed3
Sold out2

Insider trades · last 12 months

Real buys and sales

No open-market buys or sales by officers or directors in the last 12 months. Hidden: 5 stock grants, 2 tax withholdings, 2 option exercises. Press All filings to see them.

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Jan 7 · 133,333 shStock grant · Jan 7 · 25,000 shOption exercise · Jan 22 · 48,147 shShares withheld for tax · Jan 22 · $21KStock grant · Jan 28 · 150,000 shStock grant · Jan 28 · 200,000 shStock grant · Jan 28 · 45,000 shOption exercise · Sep 30 · 39,494 shShares withheld for tax · Sep 30 · $14.2K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOption exercise · Sep 30 · 39,494 shShares withheld for tax · Sep 30 · $14.2K

Last 6 months. A wider screen shows 12.

Showing 0 real trades. Hidden: 5 stock grants, 2 tax withholdings, 2 option exercises. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in ALLR

As of Jun 30, 2026

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast